Page 293«..1020..292293294295..300310..»

ElevateBio Announces the Formation of a New Company With George Daley, M.D., Ph.D., and Boston Childrens Hospital to Develop iPSC-Derived Allogeneic…

Posted: August 5, 2022 at 2:50 am

Peer-reviewed publication in Cell Stem Cell unveils a novel differentiation process from Dr. Daleys lab to develop mature immune cells from induced pluripotent stem cells (iPSCs), a potentially disruptive advantage in the development of allogeneic iPSC-derived immunotherapies

New company to leverage ElevateBios unique iPSC platform and ecosystem of enabling technologies and manufacturing capabilities to create allogeneic immune cell therapies

First company to emerge from the previously announced five-year cell and gene therapy collaboration between Boston Childrens Hospital and ElevateBio

WALTHAM, Mass., August 04, 2022--(BUSINESS WIRE)--ElevateBio, LLC (ElevateBio), a technology-driven company focused on powering transformative cell and gene therapies, today announced that it has formed a new company co-founded by George Daley, M.D, Ph.D., and Boston Childrens Hospital to develop allogeneic immune cell therapies based on a novel platform that generates functionally mature immune cells from induced pluripotent stem cells (iPSCs). This proprietary differentiation process overcomes the tendency of iPSCs to generate immature, embryonic blood cell types, and enables the generation of multiple subtypes of immune cells that display mature molecular signatures similar to T cells from adult blood. The peer-reviewed publication in the journal Cell Stem Cell showed that iPSC-derived mature T cells exhibited antitumor activity and cytokine secretion and could serve as an ideal source for the development of allogeneic "off-the-shelf" therapies.

This is the first company to emerge from the previously announced five-year collaboration between Boston Childrens Hospital and ElevateBio to accelerate the development of novel cell and gene therapies.

"At ElevateBio, we have been rapidly building fully integrated end-to-end cell and gene therapy enabling technologies and capabilities to enable the worlds most prolific scientific innovators and visionaries, such as Dr. Daley, to push the boundaries of the field and deliver powerful new therapeutic modalities for patients," said David Hallal, Chairman and CEO of ElevateBio. "This exciting new company is the first from our collaboration with Boston Childrens Hospital and is a prime example of how our integrated ecosystem our iPSC cell lines and process development capabilities, our gene editing technology, our CAR and TCR constructs, and our scale-up manufacturing capabilities creates the perfect foundation needed to turn these scientific breakthroughs into transformational medicines."

Story continues

"CAR-T therapies have revolutionized the treatment of certain blood cancers, with complete responses in many patients undergoing this type of treatment. However, current treatment strategies involve manufacturing a customized CAR-T cell product for each individual patient, which is cumbersome and labor-intensive," said Daley, senior author of the newly published Cell Stem Cell paper and whose lab is at Boston Childrens Hospital. "Our science offers an approach to circumvent these hurdles by offering an entirely new way of making allogeneic immune cell therapies that could pave the way for powerful treatments for a wide range of cancers."

Key findings shared in Cell Stem Cell publication: "EZH1 repression generates mature iPSC-derived CAR T cells with enhanced antitumor activity" (1):

A novel differentiation process discovered in Dr. George Daleys lab at Boston Childrens Hospital has been shown to promote definitive hematopoiesis and supports efficient production of mature T cells

This novel differentiation process incorporates repression of the histone methyltransferase EZH1 during iPSC differentiation to facilitate T cell maturation. The Daley lab showed previously that EZH1 is a negative regulator of lymphoid potential during embryonic blood development.

iPSC-T cells derived in a stroma-free, serum-free system following repression of EZH1, referred to as EZ-T cells, showed a molecular signature more closely resembling mature TCR T cells found in adult blood. Single cell RNA sequencing showed that activated EZ-T cells give rise to high levels of memory T cells, which promotes T cell longevity and may be essential for durable remissions in cancer patients.

In vitro studies showed EZ-T cells engineered to express anti-CD19 Chimeric Antigen Receptors (CARs) exhibited cytotoxic and cytokine-producing effector functions against CD19+ lymphoid tumor cells comparable to CAR-T cells engineered from adult blood.

In a xenograft mouse model injected with CD19+ diffuse large B-cell lymphoma (DLBCL) cells, EZ-T cells expressing anti-CD19 CARs demonstrated increased anti-tumor activity versus traditional iPSC-T cells generated without EZH1 knockdown.

(1) Jing, R., Scarfo, I., Daley, G., EZH1 repression generates mature iPSC-derived CAR T cells with enhanced antitumor activity, Cell Stem Cell, 2022

About ElevateBio:

ElevateBio is a technology-driven company built to power the development of transformative cell and gene therapies today and for many decades to come. The company has assembled industry-leading talent, built state-of-the-art facilities, and integrated diverse technology platforms, including gene editing, induced pluripotent stem cells (iPSCs), and protein, vector, and cellular engineering, necessary to drive innovation and commercialization of cellular and genetic medicines. In addition, BaseCamp is a purpose-built facility offering process innovation, process sciences, and current Good Manufacturing Practice (cGMP) manufacturing capabilities. Through BaseCamp and its enabling technologies, ElevateBio is focused on growing its collaborations with industry partners while also developing its own portfolio of cellular and genetic medicines. ElevateBio's team of scientists, drug developers, and company builders are redefining what it means to be a technology company in the world of drug development, blurring the line between technology and healthcare.

For more information, visit us at http://www.elevate.bio, or follow Elevate on LinkedIn , Twitter, or Instagram.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220804005758/en/

Contacts

Investors: Catherine Huchu@elevate.bio

Media: Courtney HeathScientPRCourtney@scientpr.com

Read this article:
ElevateBio Announces the Formation of a New Company With George Daley, M.D., Ph.D., and Boston Childrens Hospital to Develop iPSC-Derived Allogeneic...

Posted in Stem Cell Treatments | Comments Off on ElevateBio Announces the Formation of a New Company With George Daley, M.D., Ph.D., and Boston Childrens Hospital to Develop iPSC-Derived Allogeneic…

International Space Station’s MIRA: Surgery Robot to Fly in 2024 to Assist on Operations – Tech Times

Posted: August 5, 2022 at 2:47 am

The International Space Station is getting a new surgery assistant, and it is not another astronaut to join its future missions, but a surgery robot named "MIRA" that will fly to it in 2024. The new surgery robot will assist in future operations, and it is something that the ISS will test while orbiting the planet, focusing on a future use for space and health technology.

Surgery robots are massive on the planet now, and there are significant ventures to focus on for the world to experience and expand on in health technology. The International Space Station will soon receive a robot assistant to help in surgeries called "MIRA," and it stands for "miniaturized in-vivo robotic assistant."

The robot was developed by the University of Nebraska-Lincoln and medical technology company, Virtual Incision.

According toVirtual Incision's press release, the robot assistant aims to help in surgeries that the team of astronauts would test out while in space.

And while there are no significant surgeries that researchers scheduled for the astronauts, they will look into the capabilities of the robot to assist in space ventures.

Read Also: Scientists are Growing Stem Cells in Space as Part of Experiment for Treatment of Diseases

Gizmodo'sreportsays that it may be a preparation by NASA to use for long-term flights or journeys that would need more than a team of astronauts to deal with medical concerns in the future. MIRA is preparing for its arrival at the ISS by 2024 to test out its capabilities and look into operations that would help astronauts in their needs.

It will provide more than a helping hand for their needs.

There are many ventures that researchers and scientists bring to the International Space Station to test, and it aims to test its capabilities in different setups, including that of space operations. One of the ventures available there is theuse of microgravity to understand cancer tumorsand aging skin cells which would only be achievable there.

Different tests in the ISS focus on understanding what space does to human anatomy and the body, especially those flying to orbit.

Of course, the main test subjects and points of reference for the research sent to the ISS are its astronauts, cosmonauts, and other dwellers in the orbiting space laboratory. The researchers aboard it now focus on monitoring each other's health,looking into spinal scans and heart rate, among the few things they check on on a routine basis.

Now, a new robot assistant is coming to the ISS, and it specializes in surgeries and operations to help researchers know more about the conditions there and supposedly help in different ventures done in space. It may bring data and information back to the planet once it's collected, but its main goal is to test its capabilities in a different environment from the planet.

Related Article: Spectrolab Continues Innovation in Space with Advanced Solar Cell Technology

This article is owned by TechTimes

Written by Isaiah Richard

2022 TECHTIMES.com All rights reserved. Do not reproduce without permission.

See the article here:
International Space Station's MIRA: Surgery Robot to Fly in 2024 to Assist on Operations - Tech Times

Posted in Nebraska Stem Cells | Comments Off on International Space Station’s MIRA: Surgery Robot to Fly in 2024 to Assist on Operations – Tech Times

Cell Expansion Market Size, Scope, Growth Opportunities, Trends by Manufacturers And Forecast to 2029 Shanghaiist – Shanghaiist

Posted: August 5, 2022 at 2:43 am

New Jersey, United States This in-detail Cell ExpansionMarket analysis presents a review of crucial industries, which are greatly helping to impel market growth. This market study report further depicts mergers, acquisitions amid startups, strategies, product launching, and collaborations followed by industry players of the market. Industry players in the market take more efforts to go with new technology to get a competitive advantage over the cut-throat competition of the market. In order to retain their position in the market, most of organizations are recently following new developments, expansions, long-term contracts, and product developments. It further covers how COVID-19 affected a number of industries. It not affected the industries but also affected important parts of the society such as public transportation, huge gatherings, and a few mediums of travel.

Cell Expansion market research plays an important role in take business-related decisions. Making data-driven decisions is difficult due to the fast-shifting market landscape. But in this regard, it hugely helps and makes several different crucial business operations smooth around an industry. It not only predicts the business growth and market size but also focuses on gathering precise data and qualitative evaluations about the business direction. This Cell Expansion market report does an in-detail study of the volatile market environment to provide key players with significant data about key developments and market tactics. It greatly helps business players in driving important decision-making.

Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @https://www.verifiedmarketresearch.com/download-sample/?rid=23777

Key Players Mentioned in the Cell Expansion Market Research Report:

Thermo Fisher Scientific, Inc., GE Healthcare (A Wholly Owned Subsidiary of General Electric Company), Lonza Group Ltd., Becton, Dickinson and Company, Corning, Inc., Merck KGAA, Beckman Coulter, Inc. (Subsidiary of Danaher Corporation), MiltenyiBiotec, Stemcell Technologies, Terumo BCT, Inc. (A Subsidiary of Terumo Corporation).

Cell ExpansionMarket Segmentation:

Cell Expansion Market, By Product

Consumables Instruments Others

Cell Expansion Market, By Cell Type

Human Cells Animal Cells

Cell Expansion Market, By Application

Regenerative Medicine and Stem Cell Research Cancer and Cell-Based Research Others

Cell Expansion Market, By End-user

Research Institutes Biotechnology and Biopharmaceutical Companies Cell Banks Other End Users

This Cell Expansion market report assists a number of investors, shareholders as well as enterprises in understanding the tough areas of marketing ideas, technical development, key issues, and systematic analysis in order to accomplish long-term competitive gain in the industry. It goes on to talk about basic market facets along with market drivers, restraints, existing problems, forthcoming opportunities, and forecasts. This Cell Expansion market survey depicts a few exact customer insights in order to build technology strategies to make investment useful. It makes use of both primary and secondary methods to offer wide-ranging industry data to help out you in making business choices and introducing new items to the market.

Inquire for a Discount on this Premium Report@ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=23777

For Prepare TOC Our Analyst deep Researched the Following Things:

Report Overview:It includes major players of the Cell Expansion market covered in the research study, research scope, market segments by type, market segments by application, years considered for the research study, and objectives of the report.

Global Growth Trends:This section focuses on industry trends where market drivers and top market trends are shed light upon. It also provides growth rates of key producers operating in the Cell Expansion market. Furthermore, it offers production and capacity analysis where marketing pricing trends, capacity, production, and production value of the Cell Expansion market are discussed.

Market Share by Manufacturers:Here, the report provides details about revenue by manufacturers, production and capacity by manufacturers, price by manufacturers, expansion plans, mergers and acquisitions, and products, market entry dates, distribution, and market areas of key manufacturers.

Market Size by Type:This section concentrates on product type segments where production value market share, price, and production market share by product type are discussed.

Market Size by Application:Besides an overview of the Cell Expansion market by application, it gives a study on the consumption in the Cell Expansion market by application.

Production by Region:Here, the production value growth rate, production growth rate, import and export, and key players of each regional market are provided.

Consumption by Region:This section provides information on the consumption in each regional market studied in the report. The consumption is discussed on the basis of country, application, and product type.

Company Profiles:Almost all leading players of the Cell Expansion market are profiled in this section. The analysts have provided information about their recent developments in the Cell Expansion market, products, revenue, production, business, and company.

Market Forecast by Production:The production and production value forecasts included in this section are for the Cell Expansion market as well as for key regional markets.

Market Forecast by Consumption:The consumption and consumption value forecasts included in this section are for the Cell Expansion market as well as for key regional markets.

Value Chain and Sales Analysis:It deeply analyzes customers, distributors, sales channels, and value chain of the Cell Expansion market.

Key Findings:This section gives a quick look at the important findings of the research study.

For More Information or Query or Customization Before Buying, Visit @ https://www.verifiedmarketresearch.com/product/cell-expansion-market/

About Us: Verified Market Research

Verified Market Research is a leading Global Research and Consulting firm that has been providing advanced analytical research solutions, custom consulting and in-depth data analysis for 10+ years to individuals and companies alike that are looking for accurate, reliable and up to date research data and technical consulting. We offer insights into strategic and growth analyses, Data necessary to achieve corporate goals and help make critical revenue decisions.

Our research studies help our clients make superior data-driven decisions, understand market forecast, capitalize on future opportunities and optimize efficiency by working as their partner to deliver accurate and valuable information. The industries we cover span over a large spectrum including Technology, Chemicals, Manufacturing, Energy, Food and Beverages, Automotive, Robotics, Packaging, Construction, Mining & Gas. Etc.

We, at Verified Market Research, assist in understanding holistic market indicating factors and most current and future market trends. Our analysts, with their high expertise in data gathering and governance, utilize industry techniques to collate and examine data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject expertise and years of collective experience to produce informative and accurate research.

Having serviced over 5000+ clients, we have provided reliable market research services to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the worlds leading consulting firms like McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for businesses worldwide.

Contact us:

Mr. Edwyne Fernandes

Verified Market Research

US: +1 (650)-781-4080UK: +44 (753)-715-0008APAC: +61 (488)-85-9400US Toll-Free: +1 (800)-782-1768

Email: sales@verifiedmarketresearch.com

Website:- https://www.verifiedmarketresearch.com/

Read this article:
Cell Expansion Market Size, Scope, Growth Opportunities, Trends by Manufacturers And Forecast to 2029 Shanghaiist - Shanghaiist

Posted in New Jersey Stem Cells | Comments Off on Cell Expansion Market Size, Scope, Growth Opportunities, Trends by Manufacturers And Forecast to 2029 Shanghaiist – Shanghaiist

Light-activated technique helps bring cell powerhouses back into balance – University of Illinois Urbana-Champaign

Posted: August 5, 2022 at 2:41 am

CHAMPAIGN, Ill. Light-activated proteins can help normalize dysfunction within cells and could be used as a treatment for diseases such as cancer or mitochondrial diseases, new research suggests.

Researchers from the University of Cincinnati, the University of Illinois Urbana-Champaign and the University at Buffalo published the results of their study in the journal Nature Communications.

The research centers on the functions of mitochondria, organelles within a cell that act as the cells power plant and source of energy. Hundreds of mitochondria are constantly coming together a process called fusion and dividing into smaller parts a process known as fission to stay balanced in healthy cells, said study leader Jiajie Diao, a professor of cancer biology at UC. But when mitochondria are not functioning properly, there is an imbalance of this process of fission and fusion.

This imbalance can lead to a number of mitochondrial diseases, including neurodegenerative diseases like dementia and certain cancers.

Previous research found that another organelle within cells called a lysosome can play a role in mitochondria fission. When a mitochondria comes in contact with a lysosome, the lysosome can act like a pair of scissors and cut the mitochondria into smaller pieces.

The current research focused on jump-starting the fission process by bringing the lysosomes and mitochondria together within cells. This was accomplished using a technique known as optogenetics, which can precisely control specific cell functions using light.

Many proteins in plants are light-sensitive, informing plants whether it is day or night. Optogenetics borrows these light-sensitive proteins from plants and uses them in animal cells, said study coauthor Kai Zhang, a biochemistry professor at Illinois who developed the optogenetic tools for controlling mitochondria and lysosomes with blue light. By attaching such proteins to organelles, one can use light to control the interaction between them, such as mitochondria and lysosomes shown in this work.

The researchers attached two separate proteins to mitochondria and lysosomes within stem cells. When stimulated by blue light, the proteins naturally bind to each other to form one new protein, which also brings the mitochondria and lysosome into contact. Once they are brought together, the lysosome can cut the mitochondria, achieving fission.

We found that this technique can recover mitochondrial function, Diao said. Some of the cells even can go back to normal. This proves that just by using some simple light stimulation, we can at least partially recover the mitochondrial function of the cell.

This technique could be especially useful for patients with dramatically oversized mitochondria that need to be divided into smaller pieces to achieve normal cell function, Diao said. The technique also could be aimed at cancer cells, continually separating the mitochondria into smaller pieces until they can no longer function.

Eventually the cancer cell will be killed because mitochondria are their energy, Diao said. Without normal functional mitochondria, all of the cancer cells will be killed.

Since the proteins are activated by light, the optogenetic technique allows for a more targeted approach to specific cells, Diao said. Only cells exposed to the light are affected, meaning healthy cells nearby do not have their mitochondria unbalanced through the technique.

There are currently other processes that can be used to induce mitochondrial fission, but Diao said the optogenetic method is safer since it does not involve chemicals or toxic agents.

What we have is actually the natural process, were just making it faster, Diao said. So its not like a chemical or a therapy or a radiotherapy, where you need to reduce the side effects.

Diaos team is using the same technique to encourage fusion to address issues when mitochondria are unbalanced because they are too small and not coming together as they should within cells.

Further research from Zhangs lab also will include developing new optogenetic systems working with different colors of light, including green, red and infrared, since a longer wavelength will be needed to penetrate human tissue.

We would like to further expand the toolbox by introducing multicolor optogenetic systems to give us multiple ways to control how organelles behave and interact, Zhang said. For instance, one color makes organelles come together, while the other color forces them apart. This way, we can precisely control their interactions.

From the current research using human stem cells, the team hopes to progress to animal models on the way to eventually testing the technique in humans through clinical trials. At the same time, other research groups are studying the use of magnetic fields and acoustic vibrations instead of light to accomplish similar results, Diao said.

The National Institutes of Health supported this work.

Originally posted here:
Light-activated technique helps bring cell powerhouses back into balance - University of Illinois Urbana-Champaign

Posted in Illinois Stem Cells | Comments Off on Light-activated technique helps bring cell powerhouses back into balance – University of Illinois Urbana-Champaign

Single cell Analysis Market Is Likely To Witness Exponential Growth By 2030 | Danaher Corporatio, Merck Millipore, Qiagen N.V., Thermo Fisher…

Posted: August 5, 2022 at 2:41 am

Report Ocean recently added a research report on the Single-cell Analysismarket. The report includes an extensive analysis of the markets characteristics, COVID-19 impact, size and growth, segmentation, regional and country breakdowns, competitive environment, market shares, trends, and strategies. In addition, it traces the development of the market over time and projects regional market growth. It compares the market to other markets and situates it in relation to the larger market.

Other business intelligence tools include market definition, regional market opportunity, sales and revenue by region, manufacturing cost analysis, industrial chain, market effect factors analysis, market size forecast, market data and graphs and statistics, tables, bar and pie charts, and more. Obtain a thorough report (with a full TOC, more than 100 tables, figures, and charts). Extensive Analysis Impact Analysis of the Pre- and Post-COVID-19 Market Outbreak.

Single-cell Analysis Market is predicted to grow at a CAGR of ~17.1%. The market is predicted to reach $2005 million in 2026 from $763.4 million in 2020.

Single-cell Analysis Market by Product, Cell Type, Technique, End User, and by Geography .North America, Europe, Asia Pacific and Rest of the World)- Forecast to 2026Single-cell analysis is the examination & study of proteins, study of small molecules, and other cells at the single-cell level. This analysis allows the study of variations of cell-to-cell in the group of cells. The objective of the single-cell analysis is to gain insight into the mechanisms of cellular functionality, which requires an understanding of each of the cellular components, including protein content, DNA, and RNA, as well as the cellular metabolites.

Request To Download Free Sample of This Strategic Report:-https://reportocean.com/industry-verticals/sample-request?report_id=IR442

Research Methodology:The single-cell analysis market has been analyzed by utilizing the optimum combination of secondary sources and in-house methodology, along with an irreplaceable blend of primary insights. The real-time assessment of the market is an integral part of our market sizing and forecasting methodology. Our industry experts and panel of primary participants have helped in compiling relevant aspects with realistic parametric estimations for a comprehensive study. The participation share of different categories of primary participants is given below:

The information collected from this analysis is significant for cancer research for the discovery of tumor cells and genetic diagnosis. The factors such as advanced technology in products of single-cell analysis, increasing preference for customized medicine and rapidly increasing various chronic diseases such as cancer, which fuel the demand for the single-cell analysis market. However, the expensive products in the single-cell analysis are restraining market growth. Single-cell Analysis Market is predicted to grow at a CAGR of ~17.1%. The market is predicted to reach $2005 million in 2026 from $763.4 million in 2020.

SPECIAL OFFER (Avail an Up-to 30% discount on this report:-https://reportocean.com/industry-verticals/sample-request?report_id=IR442

The Single-cell Analysis Market is segmented as follows:

Based on Product:ConsumablesBeadsMicroplatesReagentsAssay KitsOther ConsumablesInstrumentsFlow CytometersNGS SystemsPCR InstrumentsSpectrophotometersMicroscopesCell CountersHCS SystemsMicroarraysOther Instruments

Based on Cell Type:Human CellsAnimal CellsMicrobial Cells

Based on Technique:Flow CytometryNext-generation SequencingPolymerase Chain ReactionMicroscopyMass SpectrometryOther Techniques

Access full Report Description, TOC, Table of Figure, Chart, etc. @:-https://reportocean.com/industry-verticals/sample-request?report_id=IR442

Based on End User:Academic & Research LaboratoriesBiotechnology & Pharmaceutical CompaniesHospitals & Diagnostic LaboratoriesCell Banks & IVF Centres

Based on Geography:North AmericaEuropeAsia PacificRest of the World

In the product based segmentation consumables segment is expected to have the largest share in the market. The reasons for the demand for consumables products are regularly purchasing the consumables compared to the instruments and the significant usage of consumables in the research and genetic exploration and segregation of RNA and DNA.

Based on cell type segmentation, the human cell segment is having the largest share in the market. The human cell is greatly used in the research laboratories due to the rising incidence of infectious diseases in the elderly population and the high investments in stem cell research.On the bases of technique, the next-generation sequencing segment is expected to have the largest share in the market due to the increasing chronic diseases and next-generation sequencing allowing researchers to perform various applications.

Further, based on end-user segmentation, the academic and research laboratories segment is expected to have the largest share in the market. The increasing number of colleges and universities of medical and high investments in life science research are the factors accelerating the demand for single-cell analysis.

Moreover, based on the geography Asia Pacific region is playing a vital role in the market share compared to other regions due to rising number of patients in countries such as China and India, growing investments in the research and development in this field and outsourcing of drug discovery services to the Asia Pacific region. In addition, North America is the second-largest contributor to the market due to the high expenditure in the research and development and increased scope for stem cell research in this region.

Query or Customization Before Buying, Visit @:-https://reportocean.com/industry-verticals/sample-request?report_id=IR442

The single-cell analysis market is expanding globally due to the increasingly advanced technology in the single-cell analysis products. The major factors accelerating the single-cell analysis market include rapidly increasing chronic diseases and cancer cases all over the world, increasing biotechnology & biopharmaceutical industries, and life science research. Although, due to high competition, the persistence of new entrants and small players is difficult in the market, and this is a challenge for market growth. The emerging markets in Asia are the future opportunities for the market.

The key market competitors in the market are Becton, Dickinson and Company, Danaher Corporatio, Merck Millipore, Qiagen N.V., Thermo Fisher Scientific, Inc, General Electric Company, BARCO, Promega Corporation, Shanghai Goodview Electronics, Fluidigm Corporation, Agilent Technologies, Inc, Nanostring Technologies, Inc., Tecan Group Ltd, Sartorius AG, LUMINEX CORPORATION, Takara Bio Inc., Takara Bio Inc., Fluxion Biosciences and Menarini Silicon Biosystems.

Moreover, the single-cell analysis has the largest scope in cancer research for the detection of the various tumor cells, preimplantation, and genetic diagnosis as the drastic increase in the cancer cases globally. The government is also supporting financially for cell-based research.The single-cell analysis market report provides the present drifts, opportunities, restraining factors, and the challengesThis report provides the overall analysis of the strategies acquired by market players based on the competitive analysisThis report gives the quantitative analysis of the market which allow the users to perceive the market factual of the overall regions

Table of Content

Market OverviewMarket DynamicsAssociated Industry AssessmentMarket Competitive LandscapeAnalysis of Leading CompaniesMarket Analysis and Forecast, By Product TypesMarket Analysis and Forecast, By ApplicationsMarket Analysis and Forecast, By RegionsConclusions and RecommendationsAppendix

Access Full Report, here:-https://reportocean.com/industry-verticals/sample-request?report_id=IR442

About Report Ocean:We are the best market research reports provider in the industry. Report Ocean believes in providing quality reports to clients to meet the top line and bottom line goals which will boost your market share in todays competitive environment. Report Ocean is a one-stop solution for individuals, organizations, and industries that are looking for innovative market research reports.

Get in Touch with Us:Report Ocean:Email:sales@reportocean.comAddress: 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611 UNITED STATES Tel: +1 888 212 3539 (US TOLL FREE)Website:https://www.reportocean.com/

Read the original here:
Single cell Analysis Market Is Likely To Witness Exponential Growth By 2030 | Danaher Corporatio, Merck Millipore, Qiagen N.V., Thermo Fisher...

Posted in Illinois Stem Cells | Comments Off on Single cell Analysis Market Is Likely To Witness Exponential Growth By 2030 | Danaher Corporatio, Merck Millipore, Qiagen N.V., Thermo Fisher…

3D Cell Culture Market Anticipated to Achieve Lucrative Growth by 2030 with 3D Biotek, LLC, Advanced Biomatrix, Inc, Becton, Dickinson and Company,…

Posted: August 5, 2022 at 2:41 am

Report Ocean recently added a research report on the 3D Cell Culture market. The report includes an extensive analysis of the markets characteristics, COVID-19 impact, size and growth, segmentation, regional and country breakdowns, competitive environment, market shares, trends, and strategies. In addition, it traces the development of the market over time and projects regional market growth. It compares the market to other markets and situates it in relation to the larger market.

Other business intelligence tools include market definition, regional market opportunity, sales and revenue by region, manufacturing cost analysis, industrial chain, market effect factors analysis, global market size forecast, market data and graphs and statistics, tables, bar and pie charts, and more. Obtain a thorough report (with a full TOC, more than 100 tables, figures, and charts). Extensive Analysis Impact Analysis of the Pre- and Post-COVID-19 Market Outbreak.

The estimated market value of 3D Cell Culture in 2020 is US$ 2,717.6 million and it is predicted that it will grow at a CAGR of 29.1%.

A 3D cell culture is an artificial environment where biological cells grow or connect with their surrounding habitats in three dimensions. It develops types of different cells and tissues formulation which is not feasible under 2D culture systems. It has more properties of tissue mutation and cell cohesion. The early-stage drug discovery and other related research have earned 3D cell structure increasing popularity which can be seen in its growing application.

Request To Download Free Sample of This Strategic Report:-https://reportocean.com/industry-verticals/sample-request?report_id=IR426

Research Methodology:The 3D cell culture market has been analyzed by utilizing the optimum combination of secondary sources and in-house methodology, along with an irreplaceable blend of primary insights. The real-time assessment of the market is an integral part of our market sizing and forecasting methodology. Our industry experts and panel of primary participants have helped in compiling relevant aspects with realistic parametric estimations for a comprehensive study. The participation share of different categories of primary participants is given below:

3D cell culture is growing at a fast pace in the healthcare environment because of the significant scale of implementations in various areas like cancer research, vitro environment, and regenerative medicine. It has the potential to understand tissue maturation and formation, organogenesis, and cell differentiation has increased its utility. Now animal prototypes in clinical testing and experiments are replaced because of its similarity with cells in vivo. The 3D cell culture market is majorly driven through the increasing usage of 3D cell culture in diagnostic centers, hospitals, pharmaceutical, and biotech companies. Which directly increases the demand for organ transplantation, tissue regeneration, and regenerative medicine.

The research report segregates the market into the following segments:

By ProductScaffold-based 3D Cell CulturesHydrogels/ECM AnalogsSolid ScaffoldsMicropatterned SurfacesScaffold-free 3D Cell CulturesLow Attachment PlatesHanging Drop Plates3D Bioreactors3D Petri DishesMicrofluidics-based 3D Cell CulturesMagnetic & Bioprinted 3D Cell Cultures

SPECIAL OFFER (Avail an Up-to 30% discount on this report:-https://reportocean.com/industry-verticals/sample-request?report_id=IR426

By ApplicationCancer & Stem Cell ResearchDrug Discovery & Toxicology TestingTissue Engineering & Regenerative Medicine

By End UserPharmaceutical & Biotechnology CompaniesResearch InstitutesCosmetics IndustryOther End Users

Some of the prominent companies in the area of 3D Cell Culture are:3D Biotek, LLCAdvanced Biomatrix, IncBectonDickinson and CompanyCorning IncorporatedKuraray Co., LtdLonza Group LtdMerck & Co., IncSynthecon IncorporatedThermo Fisher Scientific IncVWR Corporation.

Access full Report Description, TOC, Table of Figure, Chart, etc. @:-https://reportocean.com/industry-verticals/sample-request?report_id=IR426

The report also contains insight regarding technological innovations and advanced solutions for the 3D Cell Culture. The study also gives an in-depth idea about the major competitors in the market, their journey and the competitive edge via systematic analytical tools including SWOT analysis. As per Report ocean Research, the estimated market value of 3D Cell Culture in 2020 is US$ 2,717.6 million and it is predicted that it will grow at a CAGR of 29.1%.

There are three important factors which are the driving forces behind the growth of 3D Cell Culture market:

The key features which have fueled its increased its growth are:

The rise in the prevalence rate of cancerGrowing Focus on Personalized MedicineHigh Degree of Corporate Inclusion for Research

The physiologic, histologic, and functional properties of the respective tissues have given the homotypic and heterotypic 3D tissue culture models. These properties enhance the different cellular functions such as adhesion, migration, gene expression, and proliferation. The creation of duct-like structures in vitro environments can be formed by two important factors such as normal polarization and differentiation of epithelial cells as well as with the usage of 3D cultures. Moreover, the synergistic effect required for the interactions of cell-cell and cell-extracellular matrix (ECM), which can control the expression of molecules involved in cell differentiation, is also achieved in 3D cell cultures.

Query or Customization Before Buying, Visit @:-https://reportocean.com/industry-verticals/sample-request?report_id=IR426

The potential that 3D models have so that it can minimize the accompanying flaws with 2D monolayer cultures is predetermined to fuel the demand for these techniques in the near future. The rising demand from the shift of 2D to 3D technology is pushing the growth of this market. In addition, opportunistic marketing competitors are entering this segment due to its high market potential. Subsequently, this will further propel the market.

These technologies provide advanced tools that can help to explore key aspects of disease and enable demonstration of micro-environmental factors that support in-vivo tumor growth. 3D concept of artificial cell cultivation provides vast benefits in the analysis of phenotypic heterogeneity of cancers and heterotypic intercellular crosstalk for 3D Cell Culture vendors to fulfill both the residential as well as commercial sectors.

Table of Content

Market OverviewMarket DynamicsAssociated Industry AssessmentMarket Competitive LandscapeAnalysis of Leading CompaniesMarket Analysis and Forecast, By Product TypesMarket Analysis and Forecast, By ApplicationsMarket Analysis and Forecast, By RegionsConclusions and RecommendationsAppendix

Access Full Report, here:-https://reportocean.com/industry-verticals/sample-request?report_id=IR426

About Report Ocean:We are the best market research reports provider in the industry. Report Ocean believes in providing quality reports to clients to meet the top line and bottom line goals which will boost your market share in todays competitive environment. Report Ocean is a one-stop solution for individuals, organizations, and industries that are looking for innovative market research reports.

Get in Touch with Us:Report Ocean:Email:sales@reportocean.comAddress: 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611 UNITED STATES Tel: +1 888 212 3539 (US TOLL FREE)Website:https://www.reportocean.com/

View original post here:
3D Cell Culture Market Anticipated to Achieve Lucrative Growth by 2030 with 3D Biotek, LLC, Advanced Biomatrix, Inc, Becton, Dickinson and Company,...

Posted in Illinois Stem Cells | Comments Off on 3D Cell Culture Market Anticipated to Achieve Lucrative Growth by 2030 with 3D Biotek, LLC, Advanced Biomatrix, Inc, Becton, Dickinson and Company,…

Get Healthy Carson City: Breastfeeding benefits a baby’s health – Nevada Appeal

Posted: August 5, 2022 at 2:40 am

By Holland Chambers Womens, Infants, and Children Specialist

Wednesday, August 3, 2022

Breastfeeding is the natural way to nourish a baby, but that does not mean it comes easy. Most women have challenges with breastfeeding and wonder if they are making enough breast milk. This can be difficult because women do not visually see how much milk the baby is drinking, thus, it is difficult to figure out if enough milk is being produced.It is estimated that 5% of women are physically unable to produce enough breastmilk to feed their babies and less than 5% of women experience lactation failure. With this said, most new mothers do make enough milk for their baby and this should not be a major concern with breastfeeding.Breastfeeding is best for the baby and the mother, it is a great source of nutrition, with the perfect combination of protein, fat, and carbohydrates the baby needs to grow. Yes, breastmilk has the perfect macronutrients for the baby to grow, but it also has millions of live cells that include immune boosting white blood cells, stem cells, and bacteria to help aid in organ development. Breastmilk also includes growth factors, vitamins and minerals, antibodies, long chain fatty acids, oligosaccharides, and amino acid, which are all important factors in your babys development.All mothers want to make sure their babies are the healthiest they can be, but most mothers do not realize that a crucial decision, such as breastfeeding can affect their baby both now and the rest of their lives. Breast-fed babies usually live a healthier life with less incidence of chronic illnesses, food allergies, asthma, eczema, Type I and Type II diabetes, and much more that could lead to hospitalization and other health complications. Breastfed babies have a higher level of beneficial gut bacteria and healthier growth patterns than babies who are not breastfed. Breastfed babies have a lower rate of wheezing, which is one of the most common reasons infants are hospitalized or receive medical care. Breastfed babies have a lower risk of developing asthma, because of their strong gut microbiota. Formula-fed babies have a weaker gut, which can cause gut dysbacteriosis that results in a chronic inflammatory respiratory disorder, such as asthma. Breastmilk is unique to each mom and baby to benefit their individual needs Breastmilk is concentrated with bacteria that colonize the infants gut help setting the course for the babys growing immune system and metabolism Babies who are exclusively breastfed for the first 6 months have fewer ear infection and respiratory illnesses.For information on breastfeeding, contact your local WIC agency:Carson City Health and Human Services WIC900 E. Long St., Carson City775-887-2190Monday-Friday 8 a.m. to noon and 1-5 p.m.Douglas County WIC clinic1524 Highway 395 North775-283-4772Monday- Friday 8 a.m. to noon and 1-5 p.m.For additional resources and information about Carson City Health and Human Services programs and services, check out our website at http://www.gethealthycarsoncity.org, Like us on Facebook at http://www.facebook.com/cchhs, follow us on Twitter @CCHealthEd, call us at (775) 887-2190, or visit us at 900 E. Long St. in Carson City.

Originally posted here:
Get Healthy Carson City: Breastfeeding benefits a baby's health - Nevada Appeal

Posted in Nevada Stem Cells | Comments Off on Get Healthy Carson City: Breastfeeding benefits a baby’s health – Nevada Appeal

Cell Regeneration Medicine Market Analysis by Type, Application, Growth, Demand, Status, and Forecast from 2022 to 2032 – Digital Journal

Posted: August 5, 2022 at 2:36 am

As per the latest report published by Future Market Insights, a leading Market Research firm, the Cell Regeneration Medicines Market is valued at US$ 30.3 Bn and is anticipated to reach the valuation of US$ 34.3 Bn by the end of 2032 by growing at a CAGR of 14.4%. The compound annual growth rate for the forecasted period is significantly higher from the historic CAGR of 12.4%. Furthermore, the market is expected to offer an absolute dollar opportunity of US$ 96.5 Bn in the upcoming 10 years.

The Therapeutics segment generated the most revenue in the Global Cell Regeneration Medicines Market in 2021. Revenue through this category is expected to grow at a CAGR of 16.5% during the period between 2022 and 2032. This can be attributed to higher adoption of primary cell-based therapies in clinical application and their increased usage in different therapeutic indications.

The market expansion is attributed to the introduction of gene therapy, along withadvancements in stem cell and tissue engineering. The presence of several programmes and ongoing funding in R&D by government and commercial entities help towards the market development.Additionally, the regulatory approvals in this field are further clearing the present roadblocks in the market growth.

In addition, the Global Cell Regeneration Medicines Market considers Oncology to be the leading segment among Dermatology, Musculoskeletal, Immunology & Inflammation, Oncology, Cardiovascular, Ophthalmology and Other Therapeutic Categories. It is predicted to grow at a CAGR of 13.1% during the period between 2022 and 2032, while its historical CAGR stands at just 11.4%. The Oncology segments grows owing to the rising cancer patients globally, government aided cancer research, Cell therapies developmentand initiatives to reduce cancer burden.

Key Takeaways from the Market Study

The developing countries are predicted to be a potential marketwith rising rates of chronic diseases, hereditary diseases, rising geriatricpopulation and higher demanding regionsfor organs and biomaterials. However,withlow awareness of Cell Regeneration Medicine and high cost of therapies, these potential markets are difficult to capture, comments a Future Market Insights analyst.

Request Sample Report:

https://www.futuremarketinsights.com/reports/sample/rep-gb-15084

Competitive Landscape

The Cell Regeneration MedicineMarket is driven by the Market players who are expanding their product portfolios by highly investing in the R&D and Product development areas. Government aids, technological developments, regulatory approvals, mergers and acquisitions, market expansion and a diversified product offering have all helped to maintaintheenvironment competitive.

Some of the prominent companies in the global Cell Regeneration Medicine market are AstraZeneca plc, Astellas Pharma, Inc., F. Hoffmann-La Roche Ltd., Integra Lifesciences Corp., Cook Biotech, Inc., Bayer AG, Pfizer, Inc., Merck KGaA, Abbott, Vericel Corp., Novartis AG, GlaxoSmithKline (GSK), Baxter International, Inc., Takara Bio, Inc., etc.

The key developments in the Cell Regeneration Medicine Market are:

More Insights Available

Future Market Insights, in its new offering, presents an unbiased analysis of the Cell Regeneration Medicine market, presenting historical market data (2017-2021) and forecast statistics for the period of 2022-2032.

The study reveals essential insights on the basis of Product Type (Therapeutics, Tools, Banks and Services), Therapeutic category (Dermatology, Musculoskeletal, Immunology & Inflammation, Oncology, Cardiovascular, Ophthalmology and Other Therapeutic Categories) across five regions (North America, Latin America, Europe, Asia Pacific and Middle East & Africa).

Market Segments Covered in Cell Regeneration Medicine Market Analysis

By Product Type:

By Therapeutic Category:

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-15084

Table of Content

1.1. Global Market Outlook

1.2. Demand-side Trends

1.3. Supply-side Trends

1.4. Technology Roadmap Analysis

1.5. Analysis and Recommendations

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3.1. Market Dynamics

3.1.1. Drivers

3.1.2. Restraints

3.1.3. Opportunity

3.1.4. Trends

3.2. Scenario Forecast

3.2.1. Demand in Optimistic Scenario

3.2.2. Demand in Likely Scenario

3.2.3. Demand in Conservative Scenario

3.3. Opportunity Map Analysis

3.4. Investment Feasibility Matrix

3.5. PESTLE and Porters Analysis

3.6. Regulatory Landscape

3.6.1. By Key Regions

3.6.2. By Key Countries

4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021

4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032

4.2.1. Y-o-Y Growth Trend Analysis

4.2.2. Absolute $ Opportunity Analysis

Inquire Before Buying This Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-15084

Explore wide-ranging Coverage of FMIs Healthcare Market Insights Landscape:

Tibial Neuromodulation Devices Market Growth are projected to rise at a CAGR of 8.1% during the forecast period 2022-2032. The global tibial neuromodulation devices market size is anticipated to be valued at US$ 97.7 Mn in 2022 and is projected to surpass US$ 230.7 Mn by 2032

Veterinary Injectable Devices Market is poised to witness a CAGR of 2.3% during the years 2022 to 2032

Scoliosis Management Market Overview is likely to record a CAGR of 3.9% during the forecast period, up from US$ 2,942.8 Mn in 2022 to reach a valuation of US$ 4,489.0 Mn by 2032

About Us

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights Inc.Christiana Corporate, 200 Continental Drive,Suite 401, Newark, Delaware 19713, USAT: +1-845-579-5705Report: https://www.futuremarketinsights.com/reports/cell-regeneration-medicine-market

For Sales Enquiries: [emailprotected] Browse latest Market Reports:https://www.futuremarketinsights.com/reportsLinkedIn|Twitter|Blogs

The post Cell Regeneration Medicine Market Analysis by Type, Application, Growth, Demand, Status, and Forecast from 2022 to 2032 appeared first on Future Market Insights.

Read more:
Cell Regeneration Medicine Market Analysis by Type, Application, Growth, Demand, Status, and Forecast from 2022 to 2032 - Digital Journal

Posted in Cell Medicine | Comments Off on Cell Regeneration Medicine Market Analysis by Type, Application, Growth, Demand, Status, and Forecast from 2022 to 2032 – Digital Journal

Higher Hydroxyurea Exposure Tied to Better Blood Parameters in US… – Sickle Cell Anemia News

Posted: August 5, 2022 at 2:36 am

Children with sickle cell disease (SCD) exposed to higher doses of the oral therapy hydroxyurea report better blood-related clinical parameters than those with lower exposure, according to a new study from the U.S.

The favorable outcomes were linked to higher adherence to treatment, suggesting that adherence interventions have the potential to improve a range of clinical outcomes, researchers wrote.

The study, Impact of hydroxyurea dose and adherence on hematologic outcomes for children with sickle cell anemia, was published inPediatric Blood & Cancer.

Hydroxyurea is a treatment that increases the levels of fetal hemoglobin a form of hemoglobin produced during fetal development that is more effective at transporting oxygen than its adult counterpart.

The medication has been approved in the U.S. for SCD since the late 1990s, and remains the primary disease-modifying therapy in people with the condition.

Numerous studies have demonstrated that hydroxyurea treatment can lessen the risk of hospitalization, death, and complications such as vaso-occlusive crisis. Though the efficacy of hydroxyurea in SCD is well-established, the optimal dosing strategy in a real-world setting is less clear.

Recent research done in sub-Saharan Africa suggested that clinical outcomes are better among SCD children given a high dose of hydroxyurea (mean of 29.5 mg/kg per day) compared to those who got less than 20 mg/kg/day.

Now, a team of U.S. researchers conducted an analysis to see whether the same trend would be found in children with SCD treated in the U.S.

The objective of the study was to evaluate the relationship of hydroxyurea exposure, as assessed by prescribed dose of hydroxyurea and adherence, to hematological [blood-related] parameters in children with SCD in the United States, the researchers wrote.

Adherence refers to whether patients are taking medications as directed. The researchers stressed that they were looking at how much medicine patients were actually taking not just what was prescribed as a strength of their analysis.

This study used reliable and validated adherence measures as well as EMR [electronic medical record] documented prescribing data to describe actual hydroxyurea exposure, the researchers wrote.

Compared to most previously published studies that only report the prescribed dose of hydroxyurea, this analysis incorporated hydroxyurea adherence to better describe actual hydroxyurea exposure, they added.

The scientists used data from two prior clinical trials (NCT02578017 and NCT04675645), both of which had tested interventions designed to improve adherence among children with SCD on hydroxyurea.

The data covered 45 children and young adults; just over half were male, the median age was 12 years (range 219 years), and 97.8% were Black.

The patients were divided into two groups based on their exposure to hydroxyurea. A total of 22 children took on average 20 mg/kg of the medication per day and were included in the lower exposure group. The remaining 23 patients, who took more than 20 mg/kg per day, were in the higher exposure group.

The majority of patients used hydroxyurea for more than one year (71.1%) before enrolling in the study. The remaining had been using it for longer than six months. There was no significant difference in duration of hydroxyurea treatment between the two groups.

Results showed that average levels of fetal hemoglobin were significantly elevated in the higher exposure group compared to the lower exposure group (28.9% vs. 23.4%). The team noted, however, that levels were relatively high in both exposure groups, and that there was substantial variation within each group.

Mean corpuscular volume, a measure of the size of red blood cells, also was significantly higher in the higher exposure group (average of 101 vs. 93.7 femtoliters).

These favorable outcomes resulted from both higher adherence, as represented by the higher number of days of confirmed hydroxyurea exposure, and a higher prescribed hydroxyurea dose, the researchers wrote.

The team said that these results support the need to improve adherence and optimize dosing regimens for hydroxyurea, which could be explored in future research.

Larger studies are now required to determine if increasing hydroxyurea exposure via interventions focused on optimal adherence and prescribing dosages could improve clinical outcomes in children with SCD.

Link:
Higher Hydroxyurea Exposure Tied to Better Blood Parameters in US... - Sickle Cell Anemia News

Posted in Cell Medicine | Comments Off on Higher Hydroxyurea Exposure Tied to Better Blood Parameters in US… – Sickle Cell Anemia News

Postdoctoral Researcher, Seaweed Molecular Biology, Physiology and Genetics, Ryan Institute, School job with NATIONAL UNIVERSITY OF IRELAND, GALWAY |…

Posted: August 5, 2022 at 2:34 am

Postdoctoral Researcher Seaweed Molecular Biology, Physiology and Genetics, Ryan Institute, School of Natural Sciences.NUIG RES 192-22Applications are invited from suitably qualified candidates for a full time position as a Postdoctoral Researcher (Plant Molecular Biology & Metabolism) in the Plant Systems Biology research group of Dr. Ronan Sulpice at the National University of Ireland, Galway.This 24 months position is funded by the Marine Institute and is available from September 2022 to end date of August 2024.

Job Description:The successful candidate will combine advanced knowledge of molecular genetics research with large-scale metabolic and phenotypic screening of algae. The experiments will consist of large scale metabolic analyses and growth phenotyping screens, whole genome sequencing of Palmaria strains, and data will be aggregated in a built for purpose database. Traits of focus in the project will include identification of genetic markers to identify best performing strains, both for biomass quality and growth performance.Thus experimental approaches employed in the project will include DNAseq, biochemical assays, phenotyping, and extensive field- and lab-level screening.In addition to the experimental aspect of the project, the successful candidate is expected to contribute to the dissemination of the results, help to report the results, and participate in the daily life of the laboratory.

Duties: What the successful candidate will do attached to the specific post (list /bulletpoint)-Sample seaweeds-Extract DNA, and analyse NGS data generated-perform large throughput metabolic and growth analyses-collaborate with the laboratory team technically and scientifically-write papers/reports-interact with stakeholders-participate to report progress to grant agency-participate in dissemination activities-participate in lab management and co-supervision of students-may act as mentor to co-supervisor of students and have limited teaching hours

Qualifications/Skills required:

Essential Requirements:Track record in molecular biology, ideally with a background on micro- or macro-algae.PhD in Plant or seaweed biology and a good research track record that demonstrates strong capabilities and outputs.knowledge of R for analysis of large datasetsStrong proven (via publications, patents and other research outputs) research recordOrganisational, writing and report/paper drafting skills.Driving licenseSkills in biochemistry (metabolic analyses)

Desirable Requirements:Previous experience in a laboratory from the private sectorHave experience in grant writingEvidence for team working (including supervision and/or lab management experience)

Salary: 39,523- 45,609 per annum pro rata for shorter and/or part-time contracts (public sector pay policy rules pertaining to new entrants will apply).Start date: Position is available from 01/09/2022

Continuing Professional Development/Training:Researchers at NUI Galway are encouraged to avail of a range of training and development opportunities designed to support their personal career development plans.

Further information on research and working at NUI Galway is available on Research at NUI Galway

For information on moving to Ireland please see http://www.euraxess.ie

Further information about the laboratory is available at https://sulpice-lab.com/

Informal enquiries concerning the post may be made to Dr. Ronan Sulpice ronan.sulpice@nuigalway.ie

To Apply:Applications to include a covering letter, CV, and the contact details of three referees should be sent, via e-mail (in word or PDF only) to Dr. Ronan Sulpice ronan.sulpice@nuigalway.ie

Please put reference number NUIG RES 192-22 in subject line of e-mail application.

Closing date for receipt of applications is 5.00 pm 15/08/2022

We reserve the right to re-advertise or extend the closing date for this post.

National University of Ireland, Galway is an equal opportunities employer. All positions are recruited in line with Open, Transparent, Merit (OTM) and Competency based recruitment

'NUI Galway provides continuing professional development supports for all researchers seeking to build their own career pathways either within or beyond academia. Researchers are encouraged to engage with our Researcher Development Centre (RDC) upon commencing employment - see http://www.nuigalway.ie/rdc for further information.

Go here to read the rest:
Postdoctoral Researcher, Seaweed Molecular Biology, Physiology and Genetics, Ryan Institute, School job with NATIONAL UNIVERSITY OF IRELAND, GALWAY |...

Posted in Molecular Genetics | Comments Off on Postdoctoral Researcher, Seaweed Molecular Biology, Physiology and Genetics, Ryan Institute, School job with NATIONAL UNIVERSITY OF IRELAND, GALWAY |…

Page 293«..1020..292293294295..300310..»